Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating activities
Net loss	$ (9,575)	$ (8,138)
Adjustments to reconcile net loss to net cash provided by operating activities
Net restructuring, severance and other charges	(268)	262
Net legal settlements	0	150
Depreciation	1,933	1,892
Amortization	1,892	1,421
Amortization of developed technology	9,357	7,371
Deferred income taxes	44	(1,214)
Share-based compensation	2,956	3,776
Change in cash surrender value of company owned life insurance policies	12	11
Increase (Decrease) in Operating Capital	(4,632)	(3,433)
Net cash provided by operating activities	1,719	2,098
Investing activities
Capital expenditures	(1,610)	(5,289)
Capitalized software development costs	(2,189)	(7,272)
Investments in corporate-owned life insurance policies	(27)	(27)
Net cash used in investing activities	(3,826)	(12,588)
Financing activities
Repurchase of common shares to satisfy employee tax withholding	(612)	(1,190)
Principal payments under long-term obligations	(90)	(92)
Net cash used in financing activities	(702)	(1,282)
Effect of exchange rate changes on cash	(139)	132
Net decrease in cash and cash equivalents	(2,948)	(11,640)
Cash and cash equivalents at beginning of period	39,943	49,255
Cash and cash equivalents at end of period	36,995	37,615
Accrued capital expenditures	31	81
Accrued capitalized software development costs	$ 0	$ 107